Key facts
- This page summarizes Jeff Cunningham's Form 4 filing for HEALTHSTREAM INC (HSTM).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2025, 09:29.
Jeff Cunningham - 27 Feb 2025 Form 4 Insider Report for HEALTHSTREAM INC (HSTM)
- Reporting relationship
- Chief Technology Officer
- Issuer ticker
- HSTM
- Reported as of
- 27 Feb 2025
- Net transaction value
- -$19,195
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2025, 09:29:10 UTC
- Prior SEC filing
- 31 Oct 2024
- Next SEC filing
- 21 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeff Cunningham
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeff Cunningham filed Form 4 for HEALTHSTREAM INC (HSTM) on 28 Feb 2025.
Change
- Previous filing in this sequence was filed on 31 Oct 2024.
- Current net transaction value: -$19,195.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HSTM
transaction
Common Stock Holding
Options Exercise
- Transaction value
- $0
- Shares
- +2,000
- Change %
- +7.7%
- Price
- $0.000000
- Shares after
- 27,987
- Date
- 27 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
HSTM
transaction
Common Stock Holding
Tax liability
- Transaction value
- $19,195
- Shares
- -593
- Change %
- -2.1%
- Price
- $32.37
- Shares after
- 27,394
- Date
- 27 Feb 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HSTM
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,000
- Change %
- -24%
- Price
- $0.000000
- Shares after
- 6,500
- Date
- 27 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000
- Exercise price
- $0.000000
- Footnotes
- F3, F4, F5
HSTM
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- $0
- Shares
- +3,606
- Change %
- Price
- $0.000000
- Shares after
- 3,606
- Date
- 27 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,606
- Exercise price
- $0.000000
- Footnotes
- F3, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Shares acquired on vesting of restricted share units.
Footnote F2
Shares withheld for payment of tax liability.
Footnote F3
Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
Footnote F4
Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria will be established on an annual basis by the Compensation Committee of the Board of Directors. 15% vest on February 23, 2024 for the period January 1, 2023 through December 31, 2023; 20% vest on February 23, 2025 for the period January 1, 2024 through December 31, 2024; 20% vest on February 23, 2026 for the period January 1, 2025 through December 31, 2025; 20% vest on February 23, 2027 for the period January 1, 2026 through December 31, 2026; and 25% vest on February 23, 2028 for the period January 1, 2027 through December 31, 2027. Vesting is determined based on actual performance. The performance criteria for the period January 1, 2024 through December 31, 2024 was achieved; therefore 20% of the awards vested on February 23, 2025.
Footnote F5
Not applicable.
Footnote F6
Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria will be established on an annual basis by the Compensation Committee of the Board of Directors. 15% vest on February 27, 2026 for the period January 1, 2025 through December 31, 2025; 20% vest on February 27, 2027 for the period January 1, 2026 through December 31, 2026; 20% vest on February 27, 2028 for the period January 1, 2027 through December 31, 2027; 20% vest on February 27, 2029 for the period January 1, 2028 through December 31, 2028; and 25% vest on February 27, 2030 for the period January 1, 2029 through December 31, 2029. Vesting will be determined based on actual performance. RSUs that do not vest during a performance period may become eligible for vesting during the next performance period (but not in succeeding periods).